<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>West Kazakhstan Medical Journal Volume 66 Issue 2</title>
<link href="http://localhost:8080/xmlui/handle/123456789/375" rel="alternate"/>
<subtitle/>
<id>http://localhost:8080/xmlui/handle/123456789/375</id>
<updated>2026-04-24T18:39:20Z</updated>
<dc:date>2026-04-24T18:39:20Z</dc:date>
<entry>
<title>Is Botox an Alternative to Surgery for Anal Fissure?</title>
<link href="http://localhost:8080/xmlui/handle/123456789/385" rel="alternate"/>
<author>
<name>Yilmaz, Eyüp Murat</name>
</author>
<author>
<name>Karacan, Erkan</name>
</author>
<id>http://localhost:8080/xmlui/handle/123456789/385</id>
<updated>2024-07-19T10:28:26Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Is Botox an Alternative to Surgery for Anal Fissure?
Yilmaz, Eyüp Murat; Karacan, Erkan
Objective To compare the results of the lateral internal sphincterotomy(LIS) technique&#13;
and high dose botulinum toxin, which is one of the treatments applied when medical&#13;
treatment is insufficient in anal fissure.&#13;
Materials and methods The files and outpatient clinic notes of the patients who&#13;
underwent lateral internal sphincterotomy and botulinum toxin injection due to lack of&#13;
response to medical treatment due to anal fissure between May 2020 and May 2023&#13;
were examined retrospectively. Preoperative and postoperative visual analog scale&#13;
(VAS) scores, five-point horizontal scale (FPHS) scores, hospitalization times, fissure&#13;
locations, follow-up periods, anesthesia type, and postoperative complications of the&#13;
patients were recorded.&#13;
Results Total 30 LIS and 24 botulinum toxin-treated patients were included.&#13;
Hospitalization time was shorter in botulinum toxin groups than in the LIS group&#13;
(p&lt;0.001). First-week VAS score was lower than botulinum toxin injection group&#13;
(p&lt;0.001). There was no significant difference between the groups in terms of FPHS&#13;
scores, follow-up periods, and recurrence (p:0.15, p:0.07, p:0.14).&#13;
Conclusion: While LIS is faster in the early period, botulinum toxin injection can be&#13;
considered as an alternative to surgical treatment for long-term results.
Objective To compare the results of the lateral internal sphincterotomy(LIS) technique&#13;
and high dose botulinum toxin, which is one of the treatments applied when medical&#13;
treatment is insufficient in anal fissure.&#13;
Materials and methods The files and outpatient clinic notes of the patients who&#13;
underwent lateral internal sphincterotomy and botulinum toxin injection due to lack of&#13;
response to medical treatment due to anal fissure between May 2020 and May 2023&#13;
were examined retrospectively. Preoperative and postoperative visual analog scale&#13;
(VAS) scores, five-point horizontal scale (FPHS) scores, hospitalization times, fissure&#13;
locations, follow-up periods, anesthesia type, and postoperative complications of the&#13;
patients were recorded.&#13;
Results Total 30 LIS and 24 botulinum toxin-treated patients were included.&#13;
Hospitalization time was shorter in botulinum toxin groups than in the LIS group&#13;
(p&lt;0.001). First-week VAS score was lower than botulinum toxin injection group&#13;
(p&lt;0.001). There was no significant difference between the groups in terms of FPHS&#13;
scores, follow-up periods, and recurrence (p:0.15, p:0.07, p:0.14).&#13;
Conclusion: While LIS is faster in the early period, botulinum toxin injection can be&#13;
considered as an alternative to surgical treatment for long-term results.
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Demographic Features of Ulcerative Gastroduodenal Bleeding</title>
<link href="http://localhost:8080/xmlui/handle/123456789/384" rel="alternate"/>
<author>
<name>Rysmakhanov, Myltykbay</name>
</author>
<author>
<name>Kurmanbai, Gulmira</name>
</author>
<author>
<name>Koyshybayev, Anuar</name>
</author>
<author>
<name>Mukhamedgalieva, Botagoz</name>
</author>
<author>
<name>Satenova, Zhanna</name>
</author>
<author>
<name>Zhakiyev, Bazylbek</name>
</author>
<id>http://localhost:8080/xmlui/handle/123456789/384</id>
<updated>2024-07-19T10:26:25Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Demographic Features of Ulcerative Gastroduodenal Bleeding
Rysmakhanov, Myltykbay; Kurmanbai, Gulmira; Koyshybayev, Anuar; Mukhamedgalieva, Botagoz; Satenova, Zhanna; Zhakiyev, Bazylbek
Background. Gastroduodenal bleeding (GDB) is a common cause of endoscopic&#13;
examinations. This study aims to study demographic criteria in patients with ulcerative&#13;
genesis GDB during primary endoscopic examinations in a single center.&#13;
Materials and Methods. The diagnostic esophagogastroduodenoscopy (EGDS) of 231&#13;
patients with GDB of ulcerative etiology from January 2020 to December 2021 was&#13;
analyzed, all patients were with primary EGDS. The study compared the activity of&#13;
ulcerative bleeding, depending on gender and age groups.&#13;
Results. The majority of patients with ulcerative GDCS were women – 57.7%. In both&#13;
groups, duodenal ulcer was the predominant cause of GDB, 61.5% in women, and&#13;
54.2% in men. Active bleeding was observed in 8 (3.4%) patients. Among all women&#13;
and men, Forrest-II bleeding was detected in 126 (93.4%) and 86 (89.6%) patients,&#13;
respectively. In women and men, GDB is most common over the age of 50 (83.7% and&#13;
59.3%). Significant differences were observed, such as GDB occurs more often in men&#13;
at the age of 41–50 years, whereas in women it occurs more often at the age of 51–60&#13;
years (p &lt; 0.05). Bleeding activity according to Forrest did not depend on gender (p&#13;
&gt; 0.05).&#13;
Conclusion. The risk of bleeding among both women and men is higher over the age&#13;
of 50. At the same time, the activity of GDK does not depend on the gender and age&#13;
of the patient.
Background. Gastroduodenal bleeding (GDB) is a common cause of endoscopic&#13;
examinations. This study aims to study demographic criteria in patients with ulcerative&#13;
genesis GDB during primary endoscopic examinations in a single center.&#13;
Materials and Methods. The diagnostic esophagogastroduodenoscopy (EGDS) of 231&#13;
patients with GDB of ulcerative etiology from January 2020 to December 2021 was&#13;
analyzed, all patients were with primary EGDS. The study compared the activity of&#13;
ulcerative bleeding, depending on gender and age groups.&#13;
Results. The majority of patients with ulcerative GDCS were women – 57.7%. In both&#13;
groups, duodenal ulcer was the predominant cause of GDB, 61.5% in women, and&#13;
54.2% in men. Active bleeding was observed in 8 (3.4%) patients. Among all women&#13;
and men, Forrest-II bleeding was detected in 126 (93.4%) and 86 (89.6%) patients,&#13;
respectively. In women and men, GDB is most common over the age of 50 (83.7% and&#13;
59.3%). Significant differences were observed, such as GDB occurs more often in men&#13;
at the age of 41–50 years, whereas in women it occurs more often at the age of 51–60&#13;
years (p &lt; 0.05). Bleeding activity according to Forrest did not depend on gender (p&#13;
&gt; 0.05).&#13;
Conclusion. The risk of bleeding among both women and men is higher over the age&#13;
of 50. At the same time, the activity of GDK does not depend on the gender and age&#13;
of the patient.
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Cluster-Based Diagnostic for Diabetes, Insights from Europe and Asia</title>
<link href="http://localhost:8080/xmlui/handle/123456789/383" rel="alternate"/>
<author>
<name>Kudabayeva, Khatimya</name>
</author>
<author>
<name>Bazargaliyev, Yerlan</name>
</author>
<author>
<name>Veklenko, Galina</name>
</author>
<author>
<name>Tleumagambetova, Bibigul</name>
</author>
<id>http://localhost:8080/xmlui/handle/123456789/383</id>
<updated>2024-07-19T10:22:58Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Cluster-Based Diagnostic for Diabetes, Insights from Europe and Asia
Kudabayeva, Khatimya; Bazargaliyev, Yerlan; Veklenko, Galina; Tleumagambetova, Bibigul
Type 2 diabetes mellitus (T2DM) has emerged as a major global health challenge,&#13;
with its prevalence steadily rising in recent decades. The International Diabetes&#13;
Federation (IDF) Diabetes Atlas projecting that the number of individuals living with&#13;
diabetes will reach 783 million by 2045. The Asian region is particularly affected,&#13;
with over 157 million diagnosed cases in 2021, representing about 11% of the region’s&#13;
total adult population. This review aims to shed light on the heterogeneity within&#13;
T2DM, emphasizing the importance on the diversity of disease and exhibits the&#13;
different phenotypic characteristics. The focus of the review is to highlight the&#13;
significance of understanding these variations in glycemic levels, insulin resistance,&#13;
complications, heredity, lifestyle, and patient preferences to tailor effective prevention&#13;
and management strategies. A comprehensive review of recent studies is presented,&#13;
revealing the importance of personalized approaches in combating the multifaceted&#13;
challenges related to T2DM. The key findings underscore the critical need for adapting&#13;
treatment strategies to individual patient profiles, thus mitigating the burden of T2DM&#13;
and its health consequences. This manuscript underscores the pressing need for&#13;
additional research endeavors and the formulation of customized interventions to&#13;
tackle the escalating prevalence of T2DM, both on a global scale and within the&#13;
Asian region.
Type 2 diabetes mellitus (T2DM) has emerged as a major global health challenge,&#13;
with its prevalence steadily rising in recent decades. The International Diabetes&#13;
Federation (IDF) Diabetes Atlas projecting that the number of individuals living with&#13;
diabetes will reach 783 million by 2045. The Asian region is particularly affected,&#13;
with over 157 million diagnosed cases in 2021, representing about 11% of the region’s&#13;
total adult population. This review aims to shed light on the heterogeneity within&#13;
T2DM, emphasizing the importance on the diversity of disease and exhibits the&#13;
different phenotypic characteristics. The focus of the review is to highlight the&#13;
significance of understanding these variations in glycemic levels, insulin resistance,&#13;
complications, heredity, lifestyle, and patient preferences to tailor effective prevention&#13;
and management strategies. A comprehensive review of recent studies is presented,&#13;
revealing the importance of personalized approaches in combating the multifaceted&#13;
challenges related to T2DM. The key findings underscore the critical need for adapting&#13;
treatment strategies to individual patient profiles, thus mitigating the burden of T2DM&#13;
and its health consequences. This manuscript underscores the pressing need for&#13;
additional research endeavors and the formulation of customized interventions to&#13;
tackle the escalating prevalence of T2DM, both on a global scale and within the&#13;
Asian region.
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
<entry>
<title>Unveiling the Healing Potential of Avicennia marina: A Mini Review on its Medicinal Marvels</title>
<link href="http://localhost:8080/xmlui/handle/123456789/382" rel="alternate"/>
<author>
<name>Alrubaye, Aymen Abdulateef</name>
</author>
<author>
<name>Balef, Reshad Moradi</name>
</author>
<author>
<name>Kalbi, Siavash</name>
</author>
<author>
<name>Tanideh, Nader</name>
</author>
<id>http://localhost:8080/xmlui/handle/123456789/382</id>
<updated>2024-07-19T10:19:25Z</updated>
<published>2024-01-01T00:00:00Z</published>
<summary type="text">Unveiling the Healing Potential of Avicennia marina: A Mini Review on its Medicinal Marvels
Alrubaye, Aymen Abdulateef; Balef, Reshad Moradi; Kalbi, Siavash; Tanideh, Nader
This mini review delves into the therapeutic attributes of Avicennia marina, commonly&#13;
known as the Grey Mangrove, situated within mangrove ecosystems. Characterized&#13;
by unique biochemical features, A. marina has captured the attention of the scientific&#13;
community for its potential medicinal applications. Thriving in intertidal zones amidst&#13;
salinity fluctuations and environmental stressors, this resilient mangrove species has&#13;
evolved adaptive mechanisms, leading to the synthesis of secondary metabolites&#13;
with recognized pharmacological properties. Beyond its immediate relevance in&#13;
medical research, A. marina emerges as a significant player in environmental health,&#13;
especially in the context of escalating climate change challenges. The intertidal&#13;
zones it inhabits face increasing vulnerability to rising sea levels and temperature&#13;
fluctuations, emphasizing the importance of understanding its adaptive mechanisms&#13;
for both medicinal and ecological insights. Moreover, A. marina serves as a testament&#13;
to the intricate interplay between nature and human health. Bioactive compounds&#13;
found in this mangrove not only hold promise for pharmaceutical applications but also&#13;
contribute to the burgeoning field of herbal medicine. Integrating traditional knowledge&#13;
with modern scientific approaches provides a holistic understanding of the Grey&#13;
Mangrove’s therapeutic spectrum, unveiling potential herbal remedies with relevance&#13;
to contemporary healthcare practices. This dual perspective positions A. marina as&#13;
a subject of interdisciplinary research, where botanical pharmacology intersects with&#13;
ecological resilience, addressing both medical and environmental challenges.
This mini review delves into the therapeutic attributes of Avicennia marina, commonly&#13;
known as the Grey Mangrove, situated within mangrove ecosystems. Characterized&#13;
by unique biochemical features, A. marina has captured the attention of the scientific&#13;
community for its potential medicinal applications. Thriving in intertidal zones amidst&#13;
salinity fluctuations and environmental stressors, this resilient mangrove species has&#13;
evolved adaptive mechanisms, leading to the synthesis of secondary metabolites&#13;
with recognized pharmacological properties. Beyond its immediate relevance in&#13;
medical research, A. marina emerges as a significant player in environmental health,&#13;
especially in the context of escalating climate change challenges. The intertidal&#13;
zones it inhabits face increasing vulnerability to rising sea levels and temperature&#13;
fluctuations, emphasizing the importance of understanding its adaptive mechanisms&#13;
for both medicinal and ecological insights. Moreover, A. marina serves as a testament&#13;
to the intricate interplay between nature and human health. Bioactive compounds&#13;
found in this mangrove not only hold promise for pharmaceutical applications but also&#13;
contribute to the burgeoning field of herbal medicine. Integrating traditional knowledge&#13;
with modern scientific approaches provides a holistic understanding of the Grey&#13;
Mangrove’s therapeutic spectrum, unveiling potential herbal remedies with relevance&#13;
to contemporary healthcare practices. This dual perspective positions A. marina as&#13;
a subject of interdisciplinary research, where botanical pharmacology intersects with&#13;
ecological resilience, addressing both medical and environmental challenges.
</summary>
<dc:date>2024-01-01T00:00:00Z</dc:date>
</entry>
</feed>
